APCs	Antigen Presenting Cells
CAFs	Cancer Associated Fibroblasts
CTLs	Cytotoxic T Lymphocytes
CTLA-4	Cytotoxic T Lymphocyte-Associated protein-4
CTV	Clinical Target Volume
DAMPs	Damage Associated Molecular Patterns
DCs	Dendritic Cells
DLNs	Draining Lymph Nodes
ENI	Elective Nodal Irradiation
FDA	Food and Drug Administration
GITR	Glucocorticoid-Induced TNFR-Related protein
Gy	Gray
ICAMs	Intercellular Adhesion Molecules
ICAM-1	Intercellular Adhesion Molecule-1
ICD	Immunogenic Cell Death
ICI	Immune Check-point Inhibitors
IFN	Interferon
IMRT	Intensity-Modulated Radiation Therapy
IO	Immuno-Oncology
irAEs	Immune Related Adverse Events
I.T.	Intra Tumoral
i.v.	intra-venous
LLC	Lewis Lung Carcinoma
MDSCs	Myeloid Derived Suppressor Cells
MHC I	Major Histocompatibility Complex class I
MOSART	Multi-Organ Site Ablative Radiation Therapy
NKG2D	Natural Killer Group 2D
NKs	Natural Killer Cells
NSCLC	Non-Small Cell Lung Cancer
PD-1	Programmed Death-1
PD-L1	Programmed Death Ligand-1
p.t.	peri-tumoral
RT	Radiotherapy
SABR	Stereotactic ABlative Radiotherapy
s.c.	sub-cutaneous
SFRT	Spatially Fractionated RadioTherapy
TAAs	Tumor-Associated Antigens
TGF-β	Transforming Growth Factor-Beta
TIGIT	T cell ImmunoGlobulin and ITIM domain
TILs	Tumor Infiltrating Lymphocytes
TLRs	Toll-Like Receptors
TME	Tumor Microenvironment
TNF	Tumor Necrosis Factor
Tregs	regulatory T lymphocytes